ITC Limited has seen its earnings estimates slashed dramatically this year.
This isn't just routine trimming—it's one of the steepest downgrade cycles the cigarette industry has witnessed in recent years. The culprit? An unprecedented February 2026 excise duty restructuring that pushed total tax incidence on cigarettes to 60-65% of retail price, up from previous levels. This wasn't a small adjustment. It required ITC to implement price hikes of 22-23% just to offset roughly half the tax burden, with Jefferies noting that a full pass-through would need increases closer to 40%.
The earnings damage showed up clearly in Q1 FY27. Standalone net profit fell 27.1% year-on-year to ₹3,579 crore, significantly worse than the 13% decline analysts had expected. The cigarette segment took the hardest hit—segment PBIT collapsed 35.1% to ₹3,341 crore, even as gross revenue jumped 81% due to tax pass-through. This divergence between gross and net numbers tells the real story: excise duty flows through revenue but crushes profitability. Cigarette volumes declined 4-5%, which was actually better than the feared 8-10% drop, but the margin compression was severe. EBITDA margins contracted 501 basis points to 26.9%.
The stock has fallen 34% year-to-date and 33.7% over the past year. That's not just a correction—it's a capitulation. Citi argues this decline has adequately discounted the tax shock risks, especially since ITC has already passed through approximately 75% of the tax burden through calibrated price hikes. The remaining 25% should flow through gradually, limiting further earnings downside.
The brokerage points to several factors supporting its view. First, the earnings downgrade cycle appears largely complete. With FY27 and FY28 EPS already cut by 23% and 21% respectively, there's limited room for further estimate reductions. Second, ITC's mitigation actions are progressing better than expected. The company has implemented over 30 portfolio interventions, launching new variants across LSFT and Premium-DSFT segments to retain consumers and limit downtrading. Third, Citi expects cigarette profitability to improve sequentially through FY27 as pricing actions gain traction. The brokerage forecasts cigarette EBIT will decline 23% in FY27 before recovering in FY28, with the EBIT-per-stick metric approaching pre-tax-hike levels by FY27-end.
ITC's response to the tax hike has been notably different from historical patterns.
This time, it adopted a calibrated, phased approach. Price hikes came in multiple rounds—May and September 2026—rather than one shock. Classic Connect (20 sticks) moved from ₹390 to ₹428, a 9.74% increase. Gold Flake Super Star (10 sticks) rose from ₹79 to ₹89, up 12.66%. These are substantial increases, but they're staggered to prevent consumer shock and migration to illicit alternatives.
The strategy makes sense when you consider the competitive landscape. India is the world's fourth-largest illicit cigarette market, with illegal products accounting for roughly one-third of the legal industry size. Illicit cigarettes cost the exchequer an estimated ₹21,000-23,000 crore annually in lost revenue. They're priced 40-60% below legal cigarettes because they avoid all taxes. If ITC had raised prices aggressively in one go, it would have widened this price gap dramatically and accelerated volume loss to the illegal market. By staggering increases, ITC is walking a tightrope—recovering margins while protecting its 72%+ market share in the legal cigarette segment.
The causal relationship between this pricing strategy and profitability maintenance is straightforward but nuanced. In the short term, absorbing some tax impact hurts margins—that's why Q1 showed such severe profit compression. But this absorption prevents permanent volume loss. Consumers who downtrade to illicit cigarettes rarely return. By keeping legal prices relatively competitive through gradual increases, ITC preserves its consumer franchise. As the remaining 25% of tax pass-through flows through over the coming quarters, and as leaf tobacco costs moderate (showing deflationary trends), margins should recover sequentially. HDFC Securities expects near-full recovery in cigarette per-stick profitability by Q4FY27.
Despite ITC's careful pricing, volume pressure is real. Cigarette volumes fell 4-5% in Q1 FY27, and near-term headwinds persist. The price elasticity of demand varies by consumer segment—premium brand-loyal smokers show low elasticity (0.2-0.3), while price-sensitive consumers demonstrate higher elasticity (0.5-0.9). Research shows that downtrading increases with the size of price changes, especially when increases are uneven across brands. A 10% price increase in mid-priced brands can boost demand for economy brands by 2.1%. This is why ITC's well-laddered portfolio across price points is crucial—it gives consumers options to trade down within ITC's franchise rather than leaving entirely.
The competitive landscape adds complexity. The legal cigarette market is oligopolistic, with the top three players controlling about 95% of sales. ITC dominates with 72%+ share, followed by Godfrey Phillips India and VST Industries. The key dynamic is pricing coordination—competitors have increased prices "to the same extent as ITC," preventing share wars. But branded competition isn't the main threat. Illicit trade is. The Track and Trace mechanism introduced in Budget 2025 should help enforcement, but its effectiveness remains unproven at scale.
This is where new product launches become critical. ITC has introduced over 30 variants in a short span, including Gold Flake Indie Paan Sleek, Players Magic Mix, Classic World Series, Rothmans GT & XT, and American Club Clove Mint Fresh. These aren't random launches—they're strategic interventions designed to retain consumers at every price point. Premium variants drive mix improvement and margin expansion. Value offerings compete with illicit alternatives on price while offering superior quality. The early results are encouraging. Q1 volume decline of 4-5% was better than the 8-10% expected, suggesting the portfolio strategy is working.
The 34% stock correction has fundamentally changed ITC's valuation proposition.
The stock is trading near its 52-week low of ₹254.65, down 37% from the high of ₹426.40. Perhaps most importantly for income-focused investors, the dividend yield has expanded to approximately 5.4%, up from around 3.5% pre-correction. Historical analysis shows ITC has traded below current P/E levels on 60.5% of trading days over the past 494 days, indicating the valuation is in the lower quartile of its historical range.
This valuation reset explains Citi's improved risk-reward assessment, but it also highlights the divergence in analyst targets. Citi's ₹300 target implies 11.6% upside from current levels. The Bloomberg consensus of ₹326.03 suggests 21.3% upside. Jefferies is even more bullish at ₹350 (30.2% upside), while J.P. Morgan maintains a more conservative ₹310 (15.3% upside). This ₹26-30 spread isn't random—it reflects genuine differences in assumptions about earnings recovery pace, volume resilience, and valuation multiple philosophy.
The consensus uses 20-21x, closer to historical averages assuming earnings stabilize. Bullish analysts apply 22-23x, expecting multiple re-rating as visibility improves. These multiple differences alone explain much of the target price divergence. Then there's the timeline question—Citi sees FY27 as a transition year with earnings bottoming, while more optimistic analysts expect faster normalization by H2 FY27. The truth likely lies somewhere in between, which is why the consensus target of ₹326.03 represents a reasonable middle ground.
Citi's upgrade triggered an immediate market reaction—ITC shares jumped nearly 5% on October 5, hitting the day's high of ₹269.80 before settling at ₹268.55. This wasn't just noise. The stock crossed above its 30-day moving average, and trading volume was high at 49 million shares. The move signaled that at least some investors view this as a bottoming process rather than a dead cat bounce. The broader analyst consensus of 21 Buy, 15 Hold, and 2 Sell ratings reflects cautiously optimistic sentiment—a significant shift from the bearishness that prevailed through mid-2026.
But is this a sustainable turning point? The evidence suggests a gradual sentiment shift rather than an immediate broad-based reversal. Most analysts are still on Hold, preferring to see evidence of earnings stabilization before upgrading. The stock remains down 26% year-to-date, and fundamental challenges persist. Near-term earnings pressure will likely continue through Q2 and Q3 FY27 as the full impact of price changes plays out. Volume uncertainty remains, and regulatory overhang hasn't disappeared. Illicit trade competition needs to be contained through effective enforcement, not just pricing strategy.
The next 2-3 quarters will be critical. Investors should watch for sequential improvement in cigarette profitability, stabilization of volume trends, successful implementation of the remaining 25% tax pass-through, and evidence that new product variants are gaining scale. If these milestones are met, we could see further rating upgrades and multiple expansion. If not, the stock could retest its lows. For now, Citi's upgrade marks an important inflection point—recognition that the worst of the earnings downgrade cycle is over and that risk-reward has improved materially. Whether this translates into a sustained recovery depends on execution, but the valuation cushion provides downside protection even if the timeline proves longer than expected.
